{"transactions":[{"id":1871620,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2023-06-02T00:11:13.000Z","date":"2023-03-01","kind":"grant","planned":false,"acquired":true,"shares":32700,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."}],"balance_after":32700,"derivative":{"exercise_price":0.3032,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":32700},"source":{"system":"sec-edgar","filing":"0001615594-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559423000041/primary_doc.xml","form_type":"4"}},{"id":1871619,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2023-06-02T00:11:13.000Z","date":"2023-03-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":32700,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."}],"balance_after":0,"derivative":{"exercise_price":0.3032,"expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":32700},"source":{"system":"sec-edgar","filing":"0001615594-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559423000041/primary_doc.xml","form_type":"4"}},{"id":1871618,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2023-06-02T00:11:13.000Z","date":"2023-03-01","kind":"grant","planned":false,"acquired":true,"shares":10291,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."}],"balance_after":10291,"derivative":{"exercise_price":4.22,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":10291},"source":{"system":"sec-edgar","filing":"0001615594-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559423000041/primary_doc.xml","form_type":"4"}},{"id":1871617,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2023-06-02T00:11:13.000Z","date":"2023-03-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":10291,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."}],"balance_after":0,"derivative":{"exercise_price":4.22,"expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":10291},"source":{"system":"sec-edgar","filing":"0001615594-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559423000041/primary_doc.xml","form_type":"4"}},{"id":1871616,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2023-06-02T00:11:13.000Z","date":"2023-03-01","kind":"grant","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."}],"balance_after":5000,"derivative":{"exercise_price":4.55,"expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001615594-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559423000041/primary_doc.xml","form_type":"4"}},{"id":1871615,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2023-06-02T00:11:13.000Z","date":"2023-03-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant.  Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023.  Amounts reported above are pre-split."}],"balance_after":0,"derivative":{"exercise_price":4.55,"expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001615594-23-000041","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559423000041/primary_doc.xml","form_type":"4"}},{"id":2231040,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2022-06-15T20:13:17.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":32700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests in full on the first anniversary of the date of the grant."}],"balance_after":32700,"derivative":{"exercise_price":0.3032,"exercise_date":"2023-06-13","expiration_date":"2032-06-13","underlying":"Common Stock","underlying_shares":32700},"source":{"system":"sec-edgar","filing":"0001615594-22-000036","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559422000036/primary_doc.xml","form_type":"4"}},{"id":2688448,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2021-06-01T21:24:05.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":10291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests in full on 5/27/2022."}],"balance_after":10291,"derivative":{"exercise_price":4.22,"exercise_date":"2022-05-27","expiration_date":"2031-05-27","underlying":"Common Stock","underlying_shares":10291},"source":{"system":"sec-edgar","filing":"0001615594-21-000063","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559421000063/primary_doc.xml","form_type":"4"}},{"id":2688447,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T21:24:05.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":7204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Restricted Stock Units vest in full on 5/27/2022."}],"balance_after":27614,"source":{"system":"sec-edgar","filing":"0001615594-21-000063","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559421000063/primary_doc.xml","form_type":"4"}},{"id":2688446,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-01T21:19:57.000Z","date":"2019-07-18","kind":"sale","acquired":false,"shares":706,"price":10,"value":7060.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on the Form 4 originally filed was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 30, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned by reporting person following the transaction was incorrectly stated."}],"balance_after":16354,"source":{"system":"sec-edgar","filing":"0001615594-21-000062","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559421000062/primary_doc.xml","form_type":"4/A","original_submission_date":"2019-07-22"}},{"id":3032966,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-09-11T21:06:14.000Z","date":"2020-09-10","kind":"purchase","acquired":true,"shares":3000,"price":5.9096,"value":17728.8,"ownership":{"direct":true},"balance_after":6290,"source":{"system":"sec-edgar","filing":"0001615594-20-000065","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000065/primary_doc.xml","form_type":"4"}},{"id":3049498,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T21:16:25.000Z","date":"2020-08-14","kind":"purchase","acquired":true,"shares":2000,"price":7.4852,"value":14970.4,"ownership":{"direct":true},"balance_after":3290,"source":{"system":"sec-edgar","filing":"0001615594-20-000061","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000061/primary_doc.xml","form_type":"4"}},{"id":3049497,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T21:16:25.000Z","date":"2020-07-02","kind":"sale","acquired":false,"shares":236,"price":4.7,"value":1109.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019."}],"balance_after":1290,"source":{"system":"sec-edgar","filing":"0001615594-20-000061","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000061/primary_doc.xml","form_type":"4"}},{"id":3049496,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-21T21:16:25.000Z","date":"2020-04-02","kind":"sale","acquired":false,"shares":236,"price":2.87,"value":677.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019."}],"balance_after":1526,"source":{"system":"sec-edgar","filing":"0001615594-20-000061","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000061/primary_doc.xml","form_type":"4"}},{"id":3064421,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right-to-Buy)","published_at":"2020-08-07T21:50:59.000Z","date":"2020-08-04","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests as to 1/3 of the shares on each of the first three anniversaries of the date of the grant."}],"balance_after":5000,"derivative":{"exercise_price":4.55,"exercise_date":"2021-08-04","expiration_date":"2030-08-04","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001615594-20-000048","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000048/primary_doc.xml","form_type":"4"}},{"id":3315880,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-08T00:37:11.000Z","date":"2020-01-03","kind":"sale","acquired":false,"shares":236,"price":7.6,"value":1793.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019."}],"balance_after":1762,"source":{"system":"sec-edgar","filing":"0001615594-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559420000002/primary_doc.xml","form_type":"4"}},{"id":3397839,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-03T17:46:41.000Z","date":"2019-10-02","kind":"sale","acquired":false,"shares":236,"price":4.96,"value":1170.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on June 13, 2019."}],"balance_after":1998,"source":{"system":"sec-edgar","filing":"0001615594-19-000036","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559419000036/primary_doc.xml","form_type":"4"}},{"id":3457801,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-22T15:17:08.000Z","date":"2019-07-18","kind":"sale","acquired":false,"shares":706,"price":10,"value":7060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on November 20, 2017."}],"balance_after":2234,"source":{"system":"sec-edgar","filing":"0001615594-19-000029","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000161559419000029/primary_doc.xml","form_type":"4"}},{"id":3534756,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-09T00:40:24.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option to purchase shares of Calyxt, Inc. common stock (\"Stock Option\") was granted on May 6, 2019 and vests 15% on May 6, 2020 and 15% on May 6, 2021, with the remainder vesting quarterly (commencing with the third fiscal quarter of 2021) in equal installments over 42 months."}],"balance_after":7500,"derivative":{"exercise_price":15.59,"expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001127602-19-017807","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219017807/form4.xml","form_type":"4"}},{"id":3699808,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-01-08T21:09:42.000Z","date":"2019-01-04","kind":"sale","acquired":false,"shares":1117,"price":12,"value":13404.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,660 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 2,940 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":17060,"source":{"system":"sec-edgar","filing":"0001127602-19-001635","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760219001635/form4.xml","form_type":"4"}},{"id":3794003,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-10-09T20:14:38.000Z","date":"2018-10-05","kind":"sale","acquired":false,"shares":1117,"price":14.1139,"value":15765.2263,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2017."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is weighted average price. These shares were sold in multiple transactions at prices ranging from $14.08 to $14.19, inclusive. The reporting person undertakes to provide Calyxt, Inc., any security holder of Calyxt, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 16,660 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 2,940 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":18177,"source":{"system":"sec-edgar","filing":"0001127602-18-029802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218029802/form4.xml","form_type":"4"}},{"id":3891992,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-15T22:15:18.000Z","date":"2018-06-15","kind":"sale","acquired":false,"shares":706,"price":19.49,"value":13759.94,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the sale of shares to Cellectis, S.A. pursuant to a Share Purchase Agreement, dated June 13, 2018, among the reporting person, Cellectis, S.A. and the issuer to cover tax obligations of the reporting person in connection with the vesting on June 14, 2018 of restricted stock units (\"RSUs\") granted by the issuer to the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 16,660 RSUs with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017 and remain unvested; 2,940 shares will vest on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":19294,"source":{"system":"sec-edgar","filing":"0001127602-18-021066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000112760218021066/form4.xml","form_type":"4"}},{"id":4249862,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2017-07-28T01:52:12.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":29400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option to purchase Company common stock vests 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":29400,"derivative":{"exercise_price":13.29,"expiration_date":"2027-06-14","underlying":"Common Stock","underlying_shares":29400},"source":{"system":"sec-edgar","filing":"0000950103-17-007203","document":"dp78782_4-dumont.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000095010317007203/dp78782_4-dumont.xml","form_type":"4"}},{"id":4249861,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-28T01:52:12.000Z","date":"2017-07-25","kind":"purchase","acquired":true,"shares":400,"price":8,"value":3200.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents purchase of shares in the Company's directed share program in connection with the Company's initial public offering."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0000950103-17-007203","document":"dp78782_4-dumont.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000095010317007203/dp78782_4-dumont.xml","form_type":"4"}},{"id":4249860,"issuer":{"id":6658,"kind":"organization","name":"Cibus, Inc."},"owners":[{"id":112893,"kind":"person","name":"Dumont Philippe","position":1,"cik":"0001712186","reported_name":"Dumont Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-07-28T01:52:12.000Z","date":"2017-06-14","kind":"grant","acquired":true,"shares":19600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock units with respect to Calyxt, Inc. (the \"Company\") common stock vest 15% on the first anniversary of the grant date and 15% on the second anniversary of the grant date, with the remainder vesting quarterly in equal installments over the following 42 months."}],"balance_after":19600,"source":{"system":"sec-edgar","filing":"0000950103-17-007203","document":"dp78782_4-dumont.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1705843/000095010317007203/dp78782_4-dumont.xml","form_type":"4"}}]}